|

Dual-targeting VEGFR1/PD-L1 CAR-T cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Sichuan University1

Indications

  • Serous Cavity Metastatises1
  • Malignant Peritoneal Effusion1
  • Malignant Ascites1
  • Leptomeningeal Metastases1
  • Cancer1

Other1 trial

Dual-targeting VEGFR1 and PD-L1 CAR-T for Pleural, Peritoneal, or Leptomeningeal Metastases
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.